Workflow
Transcranial Magnetic Stimulation (TMS) Therapy
icon
搜索文档
Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan
Globenewswire· 2025-11-04 20:05
Delivered $37.3 million total revenue in Q3 2025, representing 11% adjusted pro forma revenue growth versus Q3 2024 Generated Greenbrook clinic revenue of $21.8 million in Q3 2025, an increase of 25% on an adjusted pro forma basis versus Q3 2024 Continued cash management improvement, with cash used in operations of $0.8 million in Q3 2025 Strengthened balance sheet in Q3 2025, ending the quarter with $34.5 million of total cash, consisting of cash, cash equivalents, and restricted cash MALVERN, Pa., Nov. 04 ...